# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
'As we round out our tenth year as a company, we believe we have a clear vision, a healthy balance sheet and the best team ...
Green Thumb Industries (OTC:GTBIF) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of ...
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already in...